OBIO’s EAHN™ evaluates applications from across Canada and selects the
most commercial-ready technologies. Utilizing industry-driven expertise in
assessing health technologies, EAHN™ has successfully partnered numerous
leading-edge technologies with Canadian health organizations to be evaluated in clinical settings. We are proud to share a few case studies describing how EAHN™ has made a difference.
Think your technology can
make a difference?
OBIO® accepts applicants based on the readiness of both their technologies and their organization. The application process will select for companies that are prepared to have their technologies evaluated in a health organization setting and whose technologies will provide value as measured against the Quadruple Aim of Healthcare (patient experience, population health, caregiver wellbeing, and cost).
Our applicants will be expected:
- To have all regulatory clearance necessary for evaluation in a clinical setting
- To be prepared for immediate scale-up and dissemination following a successful evaluation
- To have a clear and defined path forward for commercialization of their technology